Genesis HealthCare to Present at the Barclays Global Healthcare Conference on March 11, 2015
Get Alerts GEN Hot Sheet
Join SI Premium – FREE
KENNETT SQUARE, Pa., March 9, 2015 /PRNewswire/ -- Genesis HealthCare, Inc. (NYSE: GEN) today announced that George V. Hager, Jr., Chief Executive Officer, and Tom DiVittorio, Chief Financial Officer, are scheduled to present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2015, at 10:15 am Eastern Time. The conference is being held at the Loews Miami Beach Hotel in Miami, FL.
A copy of the combined slide presentation will be filed with the Securities and Exchange Commission on Form 8-K and made available on the Company's web site at www.genesishcc.com/investor-relations prior to Genesis HealthCare's scheduled appearance. A live webcast and replay will also be available on the Company's website at www.genesishcc.com/investor-relations.
About Genesis HealthCare Genesis HealthCare, Inc. (NYSE: GEN) is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's largest post-acute care providers with more than 500 skilled nursing centers and assisted/senior living communities in 34 states nationwide. Genesis subsidiaries also supply rehabilitation and respiratory therapy to more than 1,600 locations in 46 states and the District of Columbia. References made in this release to "Genesis," "the Company," "we," "us" and "our" refer to Genesis HealthCare, Inc. and each of its wholly-owned companies. Visit our website at www.genesishcc.com.
Investor Contact:Genesis HealthCareLori Mayer610-925-2000
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/genesis-healthcare-to-present-at-the-barclays-global-healthcare-conference-on-march-11-2015-300047356.html
SOURCE Genesis HealthCare
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coinbase (COIN) CEO Armstrong on X: Great progress on the SEC case - and huge win for self-custodial wallets
- Li Auto Inc. (LI) Announces Put Right Notification for 0.25% Convertible Notes due 2028
- Boundless Bio (BOLD) Prices 6.25M Share IPO at $16/sh
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!